Brief: Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb
BRIEF-Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb Nov 17 (Reuters) - Sichuan Biokin Pharmaceutical Co Ltd 688506.SS:
SAYS UNIT RECEIVED SECOND MILESTONE PAYMENT OF $250 MILLION FROM BRISTOL-MYERS SQUIBB FOR IZA-BREN AGREEMENT
Further company coverage: 688506.SS
(Reporting by Beijing Newsroom)
((yukun.zhang@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb
See all newsEvotec rises after second FDA IND acceptance in Bristol Myers Squibb partnership
AbbVie expands bispecific cancer med push with up to $2.5 billion deal with Germany's Disco
Bristol's schizophrenia drug helps Alzheimer's-related psychosis symptoms, preliminary data shows
Brief: Bristol Myers Squibb Presents First Clinical Data From Two Phase 3 Studies In The Adept Program Evaluating Karxt For Psychosis Associated With Alzheimer’S Disease
Brief: Sichuan Biokin Pharmaceutical's Unit Receives Milestone Payment From Bristol-Myers Squibb